Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from ZYUS Life Sciences ( (TSE:ZYUS) ) is now available.
ZYUS Life Sciences Corporation has secured a CAD$1.5 million unsecured loan from an independent director, with the funds intended for general working capital. Additionally, the company has extended the maturity dates of its prior unsecured loans totaling CAD$5 million to March 28, 2027, in exchange for share purchase warrants, enhancing its financial flexibility and potentially impacting its market positioning.
More about ZYUS Life Sciences
ZYUS Life Sciences Corporation is a Canadian-based life sciences company that focuses on developing and commercializing novel cannabinoid-based pharmaceutical drug candidates for pain management.
YTD Price Performance: -12.09%
Average Trading Volume: 5,629
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: C$46.87M
For a thorough assessment of ZYUS stock, go to TipRanks’ Stock Analysis page.